Deutsche Bank
ORMP icon

Deutsche Bank’s Oramed Pharmaceuticals ORMP Stock Holding History

Deutsche Bank’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$160K Buy
+33,198
New +$132K ﹤0.01% 3347
2022
Q2 		– Sell
-21,402
Closed -$185K – 4267
2022
Q1 		$185K Sell
21,402
-2,004
-9% -$20.5K ﹤0.01% 3312
2021
Q4 		$334K Buy
23,406
+4,679
+25% +$97.8K ﹤0.01% 3081
2021
Q3 		$411K Buy
18,727
+1,578
+9% +$26.9K ﹤0.01% 3173
2021
Q2 		$229K Buy
+17,149
New +$196K ﹤0.01% 3707
2020
Q1 		– Sell
-3,103
Closed -$15K – 4677
2019
Q4 		$15K Buy
+3,103
New +$11.6K ﹤0.01% 4385
2019
Q2 		– Sell
-10,527
Closed -$38K – 5451
2019
Q1 		$38K Buy
+10,527
New +$34.8K ﹤0.01% 4643
2018
Q4 		– Sell
-23,345
Closed -$114K – 5339
2018
Q3 		$114K Buy
23,345
+5,745
+33% +$29.8K ﹤0.01% 4453
2018
Q2 		$131K Sell
17,600
-7,314
-29% -$53.1K ﹤0.01% 4448
2018
Q1 		$162K Sell
24,914
-9,694
-28% -$74.8K ﹤0.01% 4296
2017
Q4 		$311K Buy
34,608
+5,174
+18% +$49.5K ﹤0.01% 3825
2017
Q3 		$292K Buy
29,434
+29,429
+588,580% +$254K ﹤0.01% 3689
2017
Q2 		$0 Hold
5
– – ﹤0.01% 5060
2017
Q1 		$0 Hold
5
– – ﹤0.01% 5055
2016
Q4 		$0 Sell
5
-5,000
-100% -$32.6K ﹤0.01% 5032
2016
Q3 		$36K Buy
5,005
+3,942
+371% +$30.6K ﹤0.01% 4334
2016
Q2 		$8K Sell
1,063
-437
-29% -$3.72K ﹤0.01% 4940
2016
Q1 		$9K Buy
1,500
+1,405
+1,479% +$9.41K ﹤0.01% 4851
2015
Q4 		$0 Buy
+95
New +$720 ﹤0.01% 5371

Other funds holding ORMP

Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $80.9B AUM 26.08% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.81B AUM 38.21% 1-Year Est. Return
GIA
Gem Investment Advisors Teaneck, New Jersey $163M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Deutsche Bank's ORMP Position: Q2 2026 in Review

Deutsche Bank opened a new position in Oramed Pharmaceuticals (ORMP) in Q2 2026: 33,198 shares worth $160K. The stake represents ﹤0.01% of the portfolio and ranks #3347 among its holdings. This is a return to the name: Deutsche Bank previously reported a position in ORMP as recently as Q1 2022.

Deutsche Bank first reported a position in ORMP in Q4 2015 and has held it in 19 quarters since. The position peaked at $411K in Q3 2021. 84 funds tracked by Wall St. Rank hold ORMP as of Q2 2026.

  • Deutsche Bank held 33,198 shares of Oramed Pharmaceuticals worth $160K as of Q2 2026.
  • Oramed Pharmaceuticals was a new Deutsche Bank position in Q2 2026.
  • Oramed Pharmaceuticals made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3347 holding.
  • Deutsche Bank first reported a position in Oramed Pharmaceuticals in Q4 2015 and has held it in 19 quarters since.
  • Deutsche Bank's Oramed Pharmaceuticals position peaked at $411K in Q3 2021.
  • 84 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.